监管影响的经济学分析  

Economic Analysis of Regulatory Impact

作　　者：曹洪杰[1] 姚立新 CAO Hong-jie;YAO Li-xin(National Institutes for Food and Drug Control;NMPA Institute of Medical Economics)

机构地区：[1]中国食品药品检定研究院 [2]国家药品监督管理局南方医药经济研究所

出　　处：《中国食品药品监管》2023年第5期42-61,共20页China Food & Drug Administration Magazine

摘　　要：有效的药品监管,需要持续改进监管的成本-效益,最大限度地持续提高医疗保健效率,实现患者获益。药品监管政策制定与实施过程中,应由专业机构从经济学视角评价药品监管,结合“三医联动”背景,从相关法规、指南、具体的监管措施入手,评价监管影响,提供客观、公正的评价,为最终决策提供依据。Effective regulation of pharmaceutical products requires continuous improvement of the cost-effectiveness of regulation,aiming to maximize healthcare efficiency and ensure patient benefits.In the process of formulating and implementing drug regulatory policies,professional institutions should evaluate drug regulation from an economic perspective.Considering the reform of pharmaceutical products,health insurance,and healthcare,this evaluation should encompass relevant regulations,guidance,and specific regulatory measures,contributing objective and unbiased evaluation to facilitate informed decision-making.

关 键 词：监管影响 经济学评价 成本-效益 经济福利 效用 

分 类 号：R95[医药卫生—药学]